ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 69852 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 69852; 2) Community: the network communities that were significantly associated with the response to NSC 69852; 3) Molecule: the relationships between components within communities and NSC 69852; 4) MDR: the compounds that were significantly associated with the NSC 69852.

NSC Compound Enrichment Correlation
NSC 758357 2-oxo-N-(pyridin-4-yl)-2-(1-tosyl-1H-indol-3-yl)acetamide 0.0278435641331422 0.29647625
NSC 763275 (E)-8-(4-chlorobenzylidene)-4-(4-chlorophenyl)-3,4,5,6,7,8-hexahydroquinazolin-2-amine 0.0278435641331422 0.047190216
NSC 764090 BMS-777607 0.0278435641331422 -0.042293516
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0278435641331424 0.34011093
NSC 281613 Ethanol, 2,2'-[[4-[[[3-chloro-4-(2-phenyl-4-thiazolyl)phenyl]imino]methyl]-3-methylphenyl]imino]bis-, dimethanesulfonate (ester) 0.0278435641331424 0.10948144
NSC 373355 Saframycin R 0.0278435641331424 0.46735901
NSC 529108 4-Fluoro-D,L-tryptophan 0.0278435641331424 0.19182609
NSC 610456 Camptothecin Derivative 0.0278435641331424 0.11283345
NSC 617743 Pyridinium, 4-(4-methoxyphenyl)-1-(4-methylphenyl)- 2,6-diphenyl-, tetrafluoroborate(1-) 0.0278435641331424 0.12304237
NSC 628000 Null 0.0278435641331424 0.32269502
Total:122  Current:84    [First] [Prev] [Next] [Last]